Open Access

Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis

  • Authors:
    • Jun Zhang
    • Rongming Xu
    • Lei Wu
    • Jihong Jiang
  • View Affiliations

  • Published online on: September 2, 2019     https://doi.org/10.3892/mmr.2019.10631
  • Pages: 3565-3572
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ankylosing spondylitis (AS) is a common chronic inflammatory autoimmune disease. Toll‑like receptors (TLRs) are involved in non‑specific immunity. In the present study, the roles of TLRs in AS were investigated. The levels of inflammatory cytokines were detected by ELISA and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The expression levels of TLRs and nuclear factor‑κB (NF‑κB) signaling‑associated factors were determined via RT‑qPCR and western blot analyses. It was observed that the levels of interleukin (IL)‑6, tumor necrosis factor‑α (TNF‑α), C‑reactive protein, TLR4 and TLR5 were increased in patients with AS, whereas those of IL‑10 and TLR3 were decreased. Pomalidomide, a TNF‑α release inhibitor, reduced the expression of IL‑6, TNF‑α, TLR4, TLR5 and phosphorylated‑p65, and upregulated that of IL‑10, TLR3 and p65 in peripheral blood mononuclear cells from patients with AS. Treatment of patients with infliximab, an anti‑TNF‑α monoclonal antibody, induced similar effects in vivo. In conclusion, it was revealed that inhibition of TNF‑α suppressed inflammatory responses in patients with AS, increased the expression of TLR3 and decreased NF‑κB signaling, and the expression of TLR4 and TLR5. The results indicated that TLRs and the NF‑κB signaling pathway were involved in the regulation of inflammatory responses in AS. These findings provided insight into the mechanisms underlying the development of AS and potential novel therapeutic approaches.

References

1 

Chen D, He J, Lu C, Zhou J, Fang K, Liu X and Xu L: Increased expression of T cell immunoglobulin and mucin domain 4 is positively associated with the disease severity of patients with ankylosing spondylitis. Inflammation. 38:935–940. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Akkoc N and Khan MA: Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: Comment on the article by Braun et al. Arthritis Rheum. 52:4048–4050. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Ng SC, Liao Z, Yu DT, Chan ES, Zhao L and Gu J: Epidemiology of spondyloarthritis in the People's Republic of China: Review of the literature and commentary. Semin Arthritis Rheum. 37:39–47. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Taurog JD, Chhabra A and Colbert RA: Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 374:2563–2574. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Sari I, Öztürk MA and Akkoc N: Treatment of ankylosing spondylitis. Turk J Med Sci. 45:416–430. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Martins NA, Furtado GE, Campos MJ, Leitão JC, Filaire E and Ferreira JP: Exercise and ankylosing spondylitis with New York modified criteria: A systematic review of controlled trials with meta-analysis. Acta Reumatol Port. 39:298–308. 2014.PubMed/NCBI

7 

Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W and Deicher H: Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol. 15:1109–1114. 1988.PubMed/NCBI

8 

Husseinzadeh N and Davenport SM: Role of toll-like receptors in cervical, endometrial and ovarian cancers: A review. Gynecol Oncol. 135:359–363. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Lim KH and Staudt LM: Toll-like receptor signaling. Cold Spring Harb Perspect Biol. 5:a0112472013. View Article : Google Scholar : PubMed/NCBI

10 

Huggins T, Haught JC, Xie S, Tansky CS, Klukowska M, Miner MC and White DJ: Quantitation of endotoxin and lipoteichoic acid virulence using toll receptor reporter gene. Am J Dent. 29:321–327. 2016.PubMed/NCBI

11 

Shimizu M: Multifunctions of dietary polyphenols in the regulation of intestinal inflammation. J Food Drug Anal. 25:93–99. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Abhyankar MM, Orr MT, Lin S, Suraju MO, Simpson A, Blust M, Pham T, Guderian JA, Tomai MA, Elvecrog J, et al: Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for entamoeba histolytica. NPJ Vaccines. 3:222018. View Article : Google Scholar : PubMed/NCBI

13 

Takakubo Y, Barreto G, Konttinen YT, Oki H and Takagi M: Role of innate immune sensors, TLRs, and NALP3 in rheumatoid arthritis and osteoarthritis. J Long Term Eff Med Implants. 24:243–251. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Zauner D, Quehenberger F, Hermann J, Dejaco C, Stradner MH, Stojakovic T, Angerer H, Rinner B and Graninger WB: Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: A pilot study. Int J Hyperthermia. 30:393–401. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Gómez R, Castro A, Martínez J, Rodríguez-García V, Burgués O, Tarín JJ and Cano A: Receptor activator of nuclear factor Kappa B (RANK) and clinicopathological variables in endometrial cancer: A study at protein and gene level. Int J Mol Sci. 19(pii): E18482018. View Article : Google Scholar : PubMed/NCBI

16 

Yang JH, Lee E, Lee B, Cho WK, Ma JY and Park KI: Ethanolic extracts of Artemisia apiacea hance improved atopic dermatitis-like skin lesions in vivo and suppressed TNF-alpha/IFN-gamma(−)induced proinflammatory chemokine production in vitro. Nutrients. 10(pii): E8062018. View Article : Google Scholar : PubMed/NCBI

17 

Taniguchi K and Karin M: NF-κB, inflammation, immunity and cancer: Coming of age. Nat Rev Immunol. 18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI

18 

Fang L, Liu J, Wan L, Zhu F, Tan B and Zhang P: Xinfeng capsule improves hypercoagulative state by inhibiting miR-155/NF-κB signaling pathway in patients with active ankylosing spondylitis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 32:1094–1098. 2016.(In Chinese). PubMed/NCBI

19 

Noort AR, Tak PP and Tas SW: Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Ther. 17:152015. View Article : Google Scholar : PubMed/NCBI

20 

Shostak K and Chariot A: EGFR and NF-κB: Partners in cancer. Trends Mol Med. 21:385–393. 2015. View Article : Google Scholar : PubMed/NCBI

21 

van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI

22 

Misra RS, Bhattacharya S, Huyck HL, Wang JC, Slaunwhite CG, Slaunwhite SL, Wightman TR, Secor-Socha S, Misra SK, Bushnell TP, et al: Flow-based sorting of neonatal lymphocyte populations for transcriptomics analysis. J Immunol Methods. 437:13–20. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Muller GW, Chen R, Huang SY, Corral LG, Wong LM, Patterson RT, Chen Y, Kaplan G and Stirling DI: Amino- substituted thalidomide analogs: Potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett. 9:1625–1630. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Hoy SM: Pomalidomide: A review in relapsed and refractory multiple myeloma. Drugs. 77:1897–1908. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Huang YT, Cheng CC, Chiu TH and Lai PC: Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer. Int J Oncol. 47:1711–1124. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, Soleimanifar N, Zavvar M and Nicknam MH: Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 100:198–204. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Nicoletti F, Zaccone P, Di Marco R, Lunetta M, Magro G, Grasso S, Meroni P and Garotta G: Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody. Endocrinology. 138:281–288. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Zaky DS and El-Nahrery EM: Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity. Int Immunopharmacol. 31:105–108. 2016. View Article : Google Scholar : PubMed/NCBI

30 

El-Wakkad A, Hassan Nel M, Sibaii H and El-Zayat SR: Proinflammatory, anti-inflammatory cytokines and adiponkines in students with central obesity. Cytokine. 61:682–687. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Urushima H, Nishimura J, Mizushima T, Hayashi N, Maeda K and Ito T: Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 308:G32–G41. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Hou C, Wu Q, Ouyang C and Huang T: Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 38:713–720. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Ji X, Zhou P, Zhong L, Xu A, Tsang ACO and Chan PKL: Smart surgical catheter for C-reactive protein sensing based on an imperceptible organic transistor. Adv Sci (Weinh). 5:17010532018. View Article : Google Scholar : PubMed/NCBI

34 

Wu Y, Potempa LA, El Kebir D and Filep JG: C-reactive protein and inflammation: Conformational changes affect function. Biol Chem. 396:1181–1197. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Frasca D and Blomberg BB: Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 17:7–19. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Rusman T, Ten Wolde S, Euser SM, van der Ploeg T, van Hall O and van der Horst-Bruinsma IE: Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: A retrospective cohort study in daily practice. Int J Rheum Dis. 21:836–842. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Shang J, Zhang Y, Jiang Y, Li Z, Duan Y, Wang L, Xiao J and Zhao Z: NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic nephropathy. Biochem Biophys Res Commun. 484:435–441. 2017. View Article : Google Scholar : PubMed/NCBI

38 

Lalancette-Hebert M, Faustino J, Thammisetty SS, Chip S, Vexler ZS and Kriz J: Live imaging of the innate immune response in neonates reveals differential TLR2 dependent activation patterns in sterile inflammation and infection. Brain Behav Immun. 65:312–327. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Satoh T and Akira S: Toll-like receptor signaling and its inducible proteins. Microbiol Spectr. Dec 4–2016.(Epub ahead of print). doi: 10.1128/microbiolspec.MCHD-0040-2016. PubMed/NCBI

40 

Sugitharini V, Pavani K, Prema A and Berla Thangam E: TLR-mediated inflammatory response to neonatal pathogens and co-infection in neonatal immune cells. Cytokine. 69:211–217. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Akira S, Takeda K and Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol. 2:675–680. 2001. View Article : Google Scholar : PubMed/NCBI

42 

Kragstrup TW, Andersen T, Holm C, Schiøttz-Christensen B, Jurik AG, Hvid M and Deleuran B: Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity. Clin Exp Immunol. 180:233–242. 2015. View Article : Google Scholar : PubMed/NCBI

43 

Assassi S, Reveille JD, Arnett FC, Weisman MH, Ward MM, Agarwal SK, Gourh P, Bhula J, Sharif R, Sampat K, et al: Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of Toll-like receptor 4 and 5. J Rheumatol. 38:87–98. 2011. View Article : Google Scholar : PubMed/NCBI

44 

De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM and Baeten D: Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum. 52:2146–2158. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Fagone P, Muthumani K, Mangano K, Magro G, Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus. Immunology. 142:594–602. 2014. View Article : Google Scholar : PubMed/NCBI

46 

Stojanovic I, Cuzzocrea S, Mangano K, Mazzon E, Miljkovic D, Wang M, Donia M, Al Abed Y, Kim J, Nicoletti F, et al: In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin Immunol. 123:11–323. 2007. View Article : Google Scholar

47 

Younan P, Ramanathan P, Graber J, Gusovsky F and Bukreyev A: The Toll-like receptor 4 antagonist eritoran protects mice from lethal filovirus challenge. MBio. 8(pii): e00226–17. 2017.PubMed/NCBI

48 

Codreanu C, Šírová K, Jarosova K and Batalov A: Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis. Curr Med Res Opin. 34:1763–1769. 2018. View Article : Google Scholar : PubMed/NCBI

49 

Osswald D, Rameau AC, Speeg-Schatz C, Terzic J and Sauer A: Clinical and epidemiological profile of pediatric uveitis, course of inflammatory uveitis treated with anti-TNF alpha. J Fr Ophtalmol. 41:447–452. 2018.(In French). View Article : Google Scholar : PubMed/NCBI

50 

Siljehult F, Ärlestig L, Eriksson C and Rantapää-Dahlqvist S: Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis. Scand J Rheumatol. 47:345–350. 2018. View Article : Google Scholar : PubMed/NCBI

51 

Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P and Keystone EC: Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: Relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol. 31:1912–1917. 2004.PubMed/NCBI

52 

Kim BY and Kim HS: Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab. Korean J Intern Med. 32:945–946. 2017. View Article : Google Scholar : PubMed/NCBI

53 

Maksymowych WP: Ankylosing spondylitis. Not just another pain in the back. Can Fam Physician. 50:257–262. 2004.PubMed/NCBI

54 

Dong M, Yu D, Duraipandiyan V and Abdullah Al-Dhabi N: The protective effect of chrysanthemum indicum extract against ankylosing spondylitis in mouse models. Biomed Res Int. 2017:82062812017. View Article : Google Scholar : PubMed/NCBI

55 

Aletaha S, Haddad L, Roozbehkia M, Bigdeli R, Asgary V, Mahmoudi M and Mirshafiey A: M2000 (β-D-Mannuronic Acid) as a novel antagonist for blocking the TLR2 and TLR4 downstream signalling pathway. Scand J Immunol. 85:122–129. 2017. View Article : Google Scholar : PubMed/NCBI

56 

Roozbehkia M, Mahmoudi M, Aletaha S, Rezaei N, Fattahi MJ, Jafarnezhad-Ansariha F, Barati A and Mirshafiey A: The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 52:191–196. 2017. View Article : Google Scholar : PubMed/NCBI

57 

Wu GJ, Lin YW, Chuang CY, Tsai HC and Chen RM: Liver nitrosation and inflammation in septic rats were suppressed by propofol via downregulating TLR4/NF-κB-mediated iNOS and IL-6 gene expressions. Life Sci. 195:25–32. 2018. View Article : Google Scholar : PubMed/NCBI

58 

Zhao Y, Liu Z and Zhang H: Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4/NF-κB signaling pathway. Exp Ther Med. 15:1505–1509. 2018.PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, J., Xu, R., Wu, L., & Jiang, J. (2019). Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis. Molecular Medicine Reports, 20, 3565-3572. https://doi.org/10.3892/mmr.2019.10631
MLA
Zhang, J., Xu, R., Wu, L., Jiang, J."Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis". Molecular Medicine Reports 20.4 (2019): 3565-3572.
Chicago
Zhang, J., Xu, R., Wu, L., Jiang, J."Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis". Molecular Medicine Reports 20, no. 4 (2019): 3565-3572. https://doi.org/10.3892/mmr.2019.10631